Firma Proteros biostructures, Autor bei PR-Web

Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca

Posted on 16. May 2022 by Firma Proteros biostructures Posted in Research / Development Tagged assays, cancer, cryo, discovery, disease, drugs, epigenetic, new, patients, protein, proteros, ray, research, royalties, with

Proteros biostructures GmbH (“Proteros”), an expert in integrated structure-based drug discovery, announces today an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) focused on the discovery and development of novel epigenetic drugs. The new multi-year agreement builds on an ongoing […]